Yourgene Health (YGEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 16.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 21.75
  • 52 Week Low: 7.75
  • Currency: UK Pounds
  • Shares Issued: 624.33m
  • Volume: 40,906
  • Market Cap: 103.01m

YGEN Overview

Yourgene Health is in the pharma and biotech sector and is currently trading at 16.50p per share. In the last year Yourgene Health 's share price has ranged from 7.75p to 21.75p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -53.8% -4.5%
ROCE 362.4%  
Latest F'cast
P/E 16.5 n/a
PEG n/a n/a
Pr/Revenue 11.6 6.2
Pr/Book 9.6  
Latest F'cast
Revenue 44.4% 86.9%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

YGEN Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-15 0.13 (7.45) (5.00)p n/a n/a n/a n/a 0.0%
31-Mar-16 2.45 (12.12) (6.00)p n/a n/a n/a n/a 0.0%
31-Mar-17 3.08 (7.85) 3.00p 3.9 n/a n/a n/a 0.0%
31-Mar-18 6.15 (9.54) (3.00)p n/a n/a n/a n/a 0.0%
31-Mar-19 8.88 3.39 1.00p 12.5 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

YGEN Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-20 16.60 (0.74) (0.11)p n/a n/a n/a n/a 0.0%
31-Mar-21 21.57 0.65 0.15p 111.4 n/a n/a n/a 0.0%
31-Mar-22 24.39 1.57 0.23p 71.0 1.2 +57% n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

YGEN Company Announcements

COVID-19 assay launched 30-Jun-2020 07:00 RNS
Issue of Share Options 19-Jun-2020 16:44 RNS
Collaboration in COVID-19 testing 16-Jun-2020 07:00 RNS

Latest YGEN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

YGEN Market Data

Currency UK Pounds
Share Price 16.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 21.75
52 Week Low 7.75
Volume 40,906
Shares Issued 624.33m
Market Cap 103.01m

YGEN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.23% below the market average48.23% below the market average48.23% below the market average48.23% below the market average48.23% below the market average
10.71% above the sector average10.71% above the sector average10.71% above the sector average10.71% above the sector average10.71% above the sector average
Price Trend
89.13% above the market average89.13% above the market average89.13% above the market average89.13% above the market average89.13% above the market average
64.91% above the sector average64.91% above the sector average64.91% above the sector average64.91% above the sector average64.91% above the sector average
Income Not Available
Growth
58.65% above the market average58.65% above the market average58.65% above the market average58.65% above the market average58.65% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

YGEN Dividends

No dividends found

Trades for 07-Jul-2020

Time Volume / Share Price
08:58 304 @ 16.38p
08:56 2,500 @ 16.05p
08:33 22,886 @ 16.05p
08:27 15,216 @ 16.39p

YGEN Key Personnel

CFO Barry Kenneth Hextall
CEO Lyn Rees
COO Keng Hsu

Top of Page